Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
Holders of 5% or more of THRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Theseus Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Theseus Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Theseus Pharmaceuticals, Inc., newest first.
No Schedule 13D or 13G filings on Theseus Pharmaceuticals, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Theseus Pharmaceuticals, Inc. shares.
No Form 144 notices for Theseus Pharmaceuticals, Inc. are on file.